Search results
Displaying 1 - 10 of 44 results
-
Consumer flyer: Ask your pharmacist for advice about your medicines
Consumer flyer: help with your medicines is available – ask your pharmacist for advice.
-
Safety Signal: Changes to the labelling of Bicillin LA®
Following international practice, the name and strength description for Bicillin LA® has been changed. The expression of the name will now be benzathine benzylpenicillin tetrahydrate. The expression of product strength will now be 1,200,000 units/2.3
-
Safe use of opioids data collection and reporting workbook (manual data capture)
Spreadsheet template for manual data capture, for the safe use of opioids data collection and reporting.
-
Patient information - Help us to help you
A leaflet about medicines safety for patients coming into hospital.
-
ALERT 17: Alteplase or tenecteplase?
An alert has been issued to highlight the need to clearly differentiate between stroke thrombolysis and myocardial infarction thrombolysis.
-
Safe Medication Management newsletters - 2010
Newsletters from the SMM programme for the year 2010
-
Acetylcysteine for the treatment of paracetamol overdose and toxicity – 2-bag dosing guidance
New dosing guidance for acetylcysteine for the treatment of paracetamol overdose and toxicity issued in January 2019.
-
Safe use of opioids collaborative information for DHB hospitals
Information document for DHBs about the breakthrough series collaborative on safe use of opioids in hospitals.
-
Just and fair culture
This training video illustrates the principles of a just and fair culture; in a just culture, people feel safe and secure to speak up when an error occurs.
-
Reducing opioid-related harm and building quality improvement capability in New Zealand: a national formative collaborative
This poster 'Reducing opioid-related harm and building quality improvement capability in New Zealand: a national formative collaborative' was presented at the IHI's 28th annual national forum on quality improvement in health care.